Integra LifeSciences (IART) Tops Q1 EPS by 12c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Integra LifeSciences (IART) PT Raised to $78 at BTIG
April 28, 2021 1:16 PM EDTBTIG analyst Ryan Zimmerman raised the price target on Integra LifeSciences (NASDAQ: IART) to $78.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy and raise our IART PT to $78 (from $74) following better-than-expected 1Q21 results. Rev. of $360.1M (1.6% Y/Y,... More
